Table 4.
Frequency of the A3 Haplotype in PROCR
Non-A3 Genotype | A3 Heterozygotes | A3 Homozygotes | Total A3 Haplotype | |
---|---|---|---|---|
ELATE patients (n=657) | 497 (77.1%) | 137 (21.2%) | 11 (1.7%) | 148 (22.9%)* |
Controls (n=627) | 501 (86.5%) | 72 (12.4%) | 6 (1.0%) | 80 (13.5%) |
P=<0.001 for ELATE patients compared to all controls